BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 17620161)

  • 1. Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.
    Silins E; Copeland J; Dillon P
    Aust N Z J Psychiatry; 2007 Aug; 41(8):649-55. PubMed ID: 17620161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A
    Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E; Daumann J
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recreational ecstasy use and depression.
    Guillot C; Greenway D
    J Psychopharmacol; 2006 May; 20(3):411-6. PubMed ID: 16574715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
    Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychiatric and cognitive long-term effects of ecstasy].
    Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms?
    Guillot C
    J Psychoactive Drugs; 2007 Mar; 39(1):31-9. PubMed ID: 17523583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible perianesthetic serotonin syndrome related to intrathecal fentanyl.
    Ozkardesler S; Gurpinar T; Akan M; Koca U; Sarikaya H; Olmez T; Elar Z
    J Clin Anesth; 2008 Mar; 20(2):143-5. PubMed ID: 18410872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The health effects of ecstasy: a literature review.
    Gowing LR; Henry-Edwards SM; Irvine RJ; Ali RL
    Drug Alcohol Rev; 2002 Mar; 21(1):53-63. PubMed ID: 12189005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity.
    Parrott AC
    Pharmacol Biochem Behav; 2002 Apr; 71(4):837-44. PubMed ID: 11888574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers.
    Matthews AJ; Bruno R
    Neuropsychobiology; 2010; 61(4):215-22. PubMed ID: 20389132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Club drug use in Germany.
    Soellner R
    Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the severity of dependence scale be usefully applied to 'ecstasy'?
    Bruno R; Matthews AJ; Topp L; Degenhardt L; Gomez R; Dunn M
    Neuropsychobiology; 2009; 60(3-4):137-47. PubMed ID: 19893331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bruxism after 3,4-methylenedioxymethamphetamine (ecstasy) abuse.
    Dinis-Oliveira RJ; Caldas I; Carvalho F; Magalhães T
    Clin Toxicol (Phila); 2010 Oct; 48(8):863-4. PubMed ID: 20515398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study.
    Patel MM; Belson MG; Wright D; Lu H; Heninger M; Miller MA
    Resuscitation; 2005 Aug; 66(2):197-202. PubMed ID: 15963623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecstasy and the concomitant use of pharmaceuticals.
    Copeland J; Dillon P; Gascoigne M
    Addict Behav; 2006 Feb; 31(2):367-70. PubMed ID: 15961251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects and risks of substituted amphetamines (Ecstasy)].
    Huether G
    Internist (Berl); 1998 Mar; 39(3):312-3. PubMed ID: 9561453
    [No Abstract]   [Full Text] [Related]  

  • 19. [New Drugs: Ectasy and Gamma-Hydroxy-Butyrate (GHB)].
    Feldman N; Croquette-Krokar M
    Vertex; 2002; 13(47):5-8. PubMed ID: 11967570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consumption and dangers of ecstasy: an amphetamine derivative with a misleading reputation of safety.
    Prescrire Int; 1999 Dec; 8(44):188-9. PubMed ID: 11503823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.